In The Debate About Cost And Efficacy, PCSK9 Inhibitors May Be The Biggest Challenge Yet

Health Affairs

Archives

The American health care system is far and away the most costly in the world. Health care reform is intended to lower costs, but they are still rising, albeit less steeply than in the past. Moderation is not however the case in the area of specialty pharmacy Read More...

Read the complete post at http://healthaffairs.org/blog/2015/02/17/in-the-debate-about-cost-and-efficacy-pcsk9-inhibitors-may-be-the-biggest-challenge-yet/


Posted Feb 17 2015, 06:00 AM by Health Affairs Blog